|
US3845770A
(en)
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US4326525A
(en)
|
1980-10-14 |
1982-04-27 |
Alza Corporation |
Osmotic device that improves delivery properties of agent in situ
|
|
US5364620A
(en)
|
1983-12-22 |
1994-11-15 |
Elan Corporation, Plc |
Controlled absorption diltiazem formulation for once daily administration
|
|
US5023252A
(en)
|
1985-12-04 |
1991-06-11 |
Conrex Pharmaceutical Corporation |
Transdermal and trans-membrane delivery of drugs
|
|
US5001139A
(en)
|
1987-06-12 |
1991-03-19 |
American Cyanamid Company |
Enchancers for the transdermal flux of nivadipine
|
|
US4992445A
(en)
|
1987-06-12 |
1991-02-12 |
American Cyanamid Co. |
Transdermal delivery of pharmaceuticals
|
|
US4902514A
(en)
|
1988-07-21 |
1990-02-20 |
Alza Corporation |
Dosage form for administering nilvadipine for treating cardiovascular symptoms
|
|
DE19929076A1
(de)
|
1999-06-25 |
2000-12-28 |
Aventis Pharma Gmbh |
Indanylsubstituierte Benzolcarbonamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen
|
|
TWI243164B
(en)
|
2001-02-13 |
2005-11-11 |
Aventis Pharma Gmbh |
Acylated indanyl amines and their use as pharmaceuticals
|
|
GB0127547D0
(en)
|
2001-11-16 |
2002-01-09 |
Astrazeneca Ab |
Chemical compounds
|
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
|
US6995144B2
(en)
*
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
|
JP2005060255A
(ja)
|
2003-08-20 |
2005-03-10 |
Nippon Nohyaku Co Ltd |
カルボキサミド類及びこれを有効成分とする有害生物防除剤
|
|
US7585881B2
(en)
|
2004-02-18 |
2009-09-08 |
Astrazeneca Ab |
Additional heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
AU2005233642A1
(en)
*
|
2004-04-13 |
2005-10-27 |
Astellas Pharma Inc. |
Polycyclic pyridines as potassium ion channel modulators
|
|
AU2007275221A1
(en)
|
2006-07-20 |
2008-01-24 |
Allen J. Borchardt |
Benzothiophene inhibitors of RHO kinase
|
|
US20080269241A1
(en)
|
2007-02-15 |
2008-10-30 |
Darin Allen |
Bicyclic aminopropyl tetrahydro-pyrazolo-pyridine modulators of cathepsin s
|
|
CN101903349B
(zh)
|
2007-08-27 |
2014-01-08 |
Abbvie德国有限责任两合公司 |
4-(4-吡啶基)-苯甲酰胺及其作为rock活性调节剂的应用
|
|
US9321727B2
(en)
|
2011-06-10 |
2016-04-26 |
Hoffmann-La Roche Inc. |
Pyridine derivatives as agonists of the CB2 receptor
|
|
JP6387360B2
(ja)
|
2013-03-14 |
2018-09-05 |
ノバルティス アーゲー |
変異ｉｄｈの阻害薬としての３−ピリミジン−４−イル−オキサゾリジン−２−オン
|
|
US10167257B2
(en)
|
2014-04-04 |
2019-01-01 |
Iomet Pharma Ltd. |
Indole derivatives for use in medicine
|
|
TW201642855A
(zh)
|
2015-03-10 |
2016-12-16 |
健臻公司 |
用於治療蛋白質病變之方法
|
|
US10538516B2
(en)
*
|
2015-03-25 |
2020-01-21 |
National Center For Geriatrics And Gerontology |
Oxadiazole derivative and pharmaceutical containing same
|
|
EP3438091A4
(en)
|
2016-03-30 |
2019-11-27 |
Ajinomoto Co., Inc. |
CONNECTION WITH INCREASING ACTIVITY FOR ACTION OF GLUCAGON LIKE PEPTIDE-1 RECEPTOR
|
|
WO2018187480A1
(en)
*
|
2017-04-04 |
2018-10-11 |
Praxis Precision Medicines, Inc. |
Compounds and their methods of use
|
|
WO2020227097A1
(en)
|
2019-05-03 |
2020-11-12 |
Praxis Precision Medicines, Inc. |
Kcnt1 inhibitors and methods of use
|
|
CA3139063A1
(en)
*
|
2019-05-03 |
2020-11-12 |
Praxis Precision Medicines, Inc. |
Kcnt1 inhibitors and methods of use
|
|
BR112021021921A2
(pt)
|
2019-05-03 |
2021-12-28 |
Nat Univ Singapore |
Agente, uso de um agente e método de tratamento ou prevenção de uma doença metabólica
|
|
AU2021241530A1
(en)
|
2020-03-23 |
2022-10-20 |
Praxis Precision Medicines, Inc. |
KCNT1 inhibitors and methods of use
|
|
KR20230035608A
(ko)
|
2020-07-06 |
2023-03-14 |
프락시스 프리시젼 메디신즈, 인크. |
Kcnt1 억제제 및 사용 방법
|
|
US11773088B2
(en)
|
2020-11-02 |
2023-10-03 |
Praxis Precision Medicines, Inc. |
KCNT1 inhibitors and methods of use
|
|
EP4267133A4
(en)
|
2020-12-22 |
2025-01-22 |
Praxis Precision Medicines, Inc. |
KCNT1 INHIBITORS AND METHODS OF USE
|
|
US20240368142A1
(en)
|
2021-04-29 |
2024-11-07 |
Praxis Precision Medicines, Inc. |
Kcnt1 inhibitors and methods of use
|
|
WO2023239839A1
(en)
|
2022-06-08 |
2023-12-14 |
Praxis Precision Medicines, Inc. |
Kcnt1 inhibitors comprising an isoxazole or oxadiazole core and methods of use
|